Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6843332 | 0.77 | NR4A2 (0.33) | CYP1A2CYP2C19 | |
| SCHEMBL8526227 | 0.70 | NR4A2 (0.32) | — | |
| SCHEMBL8525874 | 0.70 | NR4A2 (0.32) | CYP2C19 | |
| SCHEMBL3583056 | 0.70 | GRM1 (0.35) | CYP2C19 | |
| SCHEMBL8499414 | 0.68 | MAPT (0.32) | CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL8663987 | 0.64 | NR4A2 (0.33) | CYP1A2CYP2C19 | |
| SCHEMBL8525557 | 0.64 | DHFR (0.31) | — | |
| SCHEMBL6709305 | 0.63 | EDNRA (0.34) | CYP2C19 | |
| SCHEMBL7147660 | 0.62 | USP2 (0.31) | — | |
| SCHEMBL10715608 | 0.61 | SMN1; SMN2 (0.41) | CYP3A4CYP2C19HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0927156-A1 | BIPHENYL BUTYRIC ACIDS AND THEIR DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES | WARNER-LAMBERT COMPANY (US) | 1999-07-07 | — | — | EP | disclosed |
| WO-1998009940-A1 | BIPHENYL BUTYRIC ACIDS AND THEIR DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES | WARNER-LAMBERT COMPANY (US) | 1998-03-12 | — | — | WO | disclosed |